IL6 and steatosis: Herein, we show new endogenous signaling pathways in LT from DBDs, namely, IL-6/IL-1β in non-steatotic liver grafts and IL-10/L-1β in steatotic ones; these different mechanisms that depend on the presence of steatosis had not been reported to date.